Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2012
A colonic biomarker of Parkinson's disease?C Warren Olanow
Archives of Neurology|September 15, 2005
Double-blind, placebo-controlled trials for surgical interventions in Parkinson diseaseC Warren Olanow
Neurology|March 23, 2002
The role of dopamine agonists in the treatment of early Parkinson's diseaseC Warren Olanow
The Lancet. Neurology|December 20, 2005
Movement disorders: a step in the right directionC Warren Olanow
Annals of Neurology|March 12, 2014
Do prions cause Parkinson disease?: the evidence accumulatesC Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
The pathogenesis of cell death in Parkinson's disease--2007C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2014
Levodopa: effect on cell death and the natural history of Parkinson's diseaseC Warren Olanow
Neurology|April 7, 2010
The delayed-start study in Parkinson disease: can't satisfy everyoneC Warren Olanow, O Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2021
Reply to: "A New Approach to the Development of Disease-Modifying Therapies for PD"Karl Kieburtz, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?C Warren Olanow, Patrik Brundin
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2012
A colonic biomarker of Parkinson's disease?C Warren Olanow
Archives of Neurology|September 15, 2005
Double-blind, placebo-controlled trials for surgical interventions in Parkinson diseaseC Warren Olanow
Neurology|March 23, 2002
The role of dopamine agonists in the treatment of early Parkinson's diseaseC Warren Olanow
The Lancet. Neurology|December 20, 2005
Movement disorders: a step in the right directionC Warren Olanow
Annals of Neurology|March 12, 2014
Do prions cause Parkinson disease?: the evidence accumulatesC Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
The pathogenesis of cell death in Parkinson's disease--2007C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2014
Levodopa: effect on cell death and the natural history of Parkinson's diseaseC Warren Olanow
Neurology|April 7, 2010
The delayed-start study in Parkinson disease: can't satisfy everyoneC Warren Olanow, O Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2021
Reply to: "A New Approach to the Development of Disease-Modifying Therapies for PD"Karl Kieburtz, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?C Warren Olanow, Patrik Brundin
Pageof 19